PMID: 9446004Jan 31, 1998Paper

Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection

Medizinische Klinik
R FünfstückU Tietz

Abstract

A great variety of different antimicrobial chemotherapeutics is available for the treatment of urinary tract infections. Influencing the course of chronic diseases is a problem because recurrent diseases may result in disturbances of renal and bladder functions as well as in irreversible damages of the renal parenchyma. The present investigations are expected to clarify whether an effective prevention of reinfection in patients with chronically recurrent urinary tract infection is possible by a regular administration of L-methionine (Acimethin). 33 female patients were included in the examinations. Following acute disease, 23 females (aged: 47.4 +/- 13.3 years) were treated with 3 x 1 tablet of Acimethin (L-methionine) daily over a period of 26 months. Ten female patients (aged: 47.4 +/- 12.2 years) taking 1 tablet of Nevigramon (nalidixic acid) three times daily over 21.6 months served as a control group. Before starting treatment and in the middle of the therapy period control examinations were performed and following the last drug administration so as to assess the therapeutic result. No acute infection occurred during L-methionine treatment. All parameters of inflammation (leucocyte count, C-reactive protein, blood sediment...Continue Reading

References

Dec 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M Kunin
Mar 1, 1992·The Journal of Clinical Investigation·H S RugoA O'Garra
Mar 1, 1990·American Journal of Public Health·B Foxman
Jan 1, 1989·The American Journal of the Medical Sciences·J W Smith
Oct 1, 1980·Journal of Bacteriology·W Springer, W Goebel
Aug 1, 1980·Journal of Clinical Microbiology·D J EvansJ Pitt
Jun 1, 1982·Antimicrobial Agents and Chemotherapy·K VosbeckM Petignat

❮ Previous
Next ❯

Citations

Mar 11, 2008·Der Internist·G Stein, R Fünfstück
Dec 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Joerg H HolsteinLutz Claes
Apr 18, 2017·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Mario PassaroGiancarlo Balbi
May 17, 2006·The Journal of Nutrition·Peter J Garlick
Aug 24, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·H Kalhoff
Oct 9, 2014·Der Urologe. Ausg. A·W VahlensieckF Wagenlehner
Sep 13, 2006·European Neurology·T HenzeUNKNOWN Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.